S16 - Huntington's Disease: From Bench to Clinical Trials
Event Time: | Monday May 6, 2019 1:00 pm to 3:00 pm |
Topic(s): | Movement Disorders |
Director(s): | |
Description: | |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
2:40 PM - 3:00 PM | Q&A Panel with Authors | Faculty |
Speaker | Disclosure |
---|
Start Time | Pub. | Title | Presenter |
---|---|---|---|
1:00 PM | 003 | Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease |
Filipe Brogueira Rodrigues Disclosure: Dr. Brogueira Rodrigues has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GLG.
|
1:00 PM | 004 | Understanding HD Psychosis: An Analysis from the ENROLL-HD Database |
Disclosure: Dr. Jaini has nothing to disclose.
|
1:00 PM | 005 | Translational Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling Strategy to Support RG6042 Dose Selection in Huntington’s Disease (HD) |
Disclosure: Dr. Sanwald Ducray has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with F.Hoffmann-La Roche Ltd..
|
1:00 PM | 006 | The Biodistribution and Tolerability of rAAV5-miHTT after Bilateral Intra-striatal Delivery to Non-human Primates |
Disclosure: Dr. de Haan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with uniQure, Inc. Dr. de Haan has received research support from uniQure, Inc.
|
1:00 PM | 007 | The Efficacy and Safety Results of Laquinimod as a Treatment for Huntington Disease (LEGATO-HD) |
Disclosure: Dr. Reilmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion Pharmaceuticals, AOP Orphan Pharmaceuticals, CHDI Foundation, Desitin, Hoffmann-LaRoche, Ipsen, Ionis Pharmaceuticals, Mitoconix, Neurosearch, Novartis, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Temmler Pharma GmbHT, Teva, UniQure, UniQure, Huntington Study Group, European Huntington Disease Network. Dr. Reilmann has received research support from Teva Pharmaceuticals, Amarin Neuroscience, AOP Orphan Pharmaceuticals, CHDI Foundation, Hoffmann-LaRoche, Ipsen, Neurosearch, Novartis, Pfizer, Siena Biotech, UniQure, European Huntington Disease Network, Bundesministerium Bildung und Forschung (BMBF), Cure Huntington Disease Initiative Foundation, Deutsche Forschungsgemeinschaft, Deutsches Zentrum Neurodegeneration und Entzndung (DZNE), European Union 7th Framework Program (EU-FP7).
|
1:00 PM | 008 | Preliminary Report on the Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells infused intravenously in Parkinson’s disease Patients |
Disclosure: Dr. Schiess has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Medtronic. Dr. Schiess has received research support from Medtronic.
|
1:00 PM | 009 | Innovative Recruitment Strategies Increase Diversity of Participation in the Fox Insight Longitudinal Cohort |
Disclosure: Dr. Dobkin has nothing to disclose.
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C6 -
Therapy of Movement Disorders: A Case-based Approach
David Riley MD |
9:30 AM-11:30 AM |
C18 -
Cerebellar and Afferent Ataxias: Diagnosis and Management
Massimo Pandolfo MD, FAAN |
1:30 PM-3:30 PM |
C34 -
Evaluating Tremor in the Office
Andres Deik Acosta Madiedo MD |
2:30 PM-3:15 PM |
Dancing with Parkinson's
Diviya Kaul MD |
4:15 PM-5:30 PM |
Hot Topics Plenary Session
Eric Klawiter MD, FAAN |
7:00 AM-9:00 AM |
---|
C42 -
The Dystonias: Diagnosis, Treatment and Update on Etiologies
Rachel Saunders-Pullman MD |
11:30 AM-6:30 PM |
P1 -
Poster Session 1
|
1:00 PM-3:00 PM |
C51 -
Balance and Gait Disorders
Alfonso Fasano MD, PhD |
S4 -
Clinical Trials in Movement Disorders
|
3:30 PM-5:30 PM |
C67 -
Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
C72 -
Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease
LynnMarie Trotti MD |
N1 -
Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan
Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN |
S10 -
Biomarkers in Movement Disorders
|
7:00 AM-9:00 AM |
---|
C83 -
Diagnosis and Treatment of Functional Movement Disorders
Mark Hallett MD, FAAN |
C87 -
Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity
(Registration Required)
Allison Brashear MD, MBA, FAAN |
11:30 AM-6:30 PM |
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
C93 -
Paroxysmal Movement Disorders
Kailash Bhatia MD, FAAN |
1:00 PM-5:30 PM |
C105 -
Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia
(Registration Required)
Diego Torres-Russotto MD, FAAN |
3:30 PM-5:30 PM |
C117 -
Tourette Syndrome: Assessment and Management
Tamara Pringsheim MD, FAAN |
5:00 PM-5:45 PM |
Careers in Movement Disorders
Stanley Fahn MD, FAAN |
7:00 AM-9:00 AM |
---|
C127 -
Hyperkinetic Movement Disorders: Videodiagnosis and Treatment
Steven Frucht MD |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C137 -
Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders
Michael Pourfar MD |
3:30 PM-5:30 PM |
C155 -
Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders
Leonard Verhagen Metman MD, PhD |
IS2 -
Invited Science: Movement Disorders
Deborah Hall MD, PhD, FAAN |
7:00 AM-9:00 AM |
---|
C168 -
Parkinson's Disease Update
Melissa Nirenberg MD, PhD, FAAN |
C170 -
Video EEG: Name That Spell
Amy Crepeau MD |
8:00 AM-8:45 AM |
Complementary Therapies in Parkinson's Disease
Veronica Santini MD, MA |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-1:45 PM |
Understanding the AAN's Latest Guidelines
Tamara Pringsheim MD, FAAN |
1:00 PM-3:00 PM |
C179 -
Nonmotor Manifestations of Parkinson's Disease I
Jennifer Goldman MD, MS, FAAN |
C185 -
Actualización en trastornos del movimiento (Update in Movement Disorders)
Andres Deik Acosta Madiedo MD |
3:30 PM-5:30 PM |
C196 -
Nonmotor Manifestations of Parkinson's Disease II
Jennifer Goldman MD, MS, FAAN |
N5 -
Neuroscience in the Clinic: Wearable Technology
Deborah Hall MD, PhD, FAAN, Eric Klawiter MD, FAAN |
S41 -
Imaging in Movement Disorders
|
7:00 AM-9:00 AM |
---|
C209 -
Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease
Irene Litvan MD, FAAN |
11:30 AM-6:30 PM |
P5 -
Poster Session 5
|
1:00 PM-3:00 PM |
C220 -
Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia
Joohi Jimenez Shahed MD |
3:30 PM-5:30 PM |
C233 -
Therapy in Neurology IV: Movement Disorders and Stroke
David Dodick MD, FAAN |
C234 -
Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics
Shyamal Mehta MD, PhD |
S53 -
Movement Disorders: Genetics and Clinical Features
|
7:00 PM-10:00 PM |
C240 -
Case Studies: Unusual Movement Disorders
Kailash Bhatia MD, FAAN |
7:00 AM-9:00 AM |
---|
C246 -
Hot Topics and Controversies in Parkinson's Disease
Melissa Nirenberg MD, PhD, FAAN |
1:00 PM-3:00 PM |
C253 -
Update in Movement Disorders
Alfonso Fasano MD, PhD |